Renalytix plc SEC filings RENXF

Renalytix plc has 233 filings in SEC EDGAR's recent list, going back to May 15, 2020. Its latest annual report, Form 10-K, was filed on Sep 30, 2024 for the period ended Jun 30, 2024. The latest quarterly report (Form 10-Q) was filed on Nov 19, 2024, covering the quarter ended Sep 30, 2024. The most recent current report (Form 8-K) was filed on Jan 16, 2025 (regulation fd disclosure). The company's fiscal year ends on June 30.

Form Description Filed Period
10-K Annual report Sep 30, 2024 Jun 30, 2024
ARS Annual report to shareholders Nov 17, 2023 Jun 30, 2023
10-K/A Amended annual report Oct 6, 2023 Jun 30, 2023
10-K Annual report Sep 28, 2023 Jun 30, 2023
20-F Annual report (foreign issuer) Oct 31, 2022 Jun 30, 2022
20-F/A Amended annual report (foreign issuer) Aug 1, 2022 Jun 30, 2021
20-F/A Amended annual report (foreign issuer) Jan 27, 2022 Jun 30, 2021
20-F Annual report (foreign issuer) Oct 21, 2021 Jun 30, 2021
20-F/A Amended annual report (foreign issuer) Nov 10, 2020 Jun 30, 2020
20-F Annual report (foreign issuer) Oct 28, 2020 Jun 30, 2020

Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
RNLXY (OTC), RENXF (OTC)
Fiscal year ends
June 30
Incorporated in
United Kingdom
Headquarters
London
SEC filer status
, Emerging growth company
SEC CIK
1811115
Former names
Renalytix AI plc (until Jun 25, 2021)

Other Services-Medical Laboratories companies

All 29 Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.